(PVH) PVH - Overview
Stock: Apparel, Footwear, Accessories, Underwear, Fragrance
| Risk 5d forecast | |
|---|---|
| Volatility | 39.2% |
| Relative Tail Risk | -9.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.02 |
| Alpha | -31.88 |
| Character TTM | |
|---|---|
| Beta | 1.515 |
| Beta Downside | 1.262 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.90% |
| CAGR/Max DD | -0.08 |
EPS (Earnings per Share)
Revenue
Description: PVH PVH March 01, 2026
PVH Corp. (NYSE: PVH) is a global apparel company that markets a broad portfolio of brands-including Tommy Hilfiger, Calvin Klein, and various heritage and licensed lines-across men’s, women’s and children’s categories. Its operations are organized into five segments: Tommy Hilfiger North America, Tommy Hilfiger International, Calvin Klein North America, Calvin Klein International, and Heritage Brands Wholesale, covering everything from apparel and footwear to home furnishings and accessories sold through wholesale, company-owned stores, outlets, and digital channels.
In FY 2023 the company generated $9.9 billion in revenue, posting an adjusted EPS of $2.10 and an operating margin of 10.5%. E-commerce sales accelerated 12% year-over-year, now representing roughly 22% of total revenue, while inventory turnover improved to 4.2 x, reflecting tighter supply-chain management. For FY 2024 the firm has raised its guidance, targeting a 4% top-line growth driven by continued expansion in the Asia-Pacific market and higher-margin “premium casual” product mixes.
Key macro drivers include a gradual easing of U.S. inflation to 2.8%, which is supporting discretionary spending, and a persistent consumer shift toward digitally native and sustainably sourced apparel-trends that are bolstering demand for PVH’s higher-priced, brand-focused offerings. Off-price and wholesale channels remain under pressure, but the company’s focus on direct-to-consumer growth is helping to offset that headwind.
For a deeper dive into PVH’s valuation metrics, you might explore ValueRay’s analysis.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 340.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.49 > 1.0 |
| NWC/Revenue: 11.80% < 20% (prev 8.93%; Δ 2.87% < -1%) |
| CFO/TA 0.05 > 3% & CFO 583.7m > Net Income 340.8m |
| Net Debt (4.10b) to EBITDA (480.4m): 8.53 < 3 |
| Current Ratio: 1.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.9m) vs 12m ago -14.92% < -2% |
| Gross Margin: 57.69% > 18% (prev 0.60%; Δ 5709 % > 0.5%) |
| Asset Turnover: 77.81% > 50% (prev 78.03%; Δ -0.22% > 0%) |
| Interest Coverage Ratio: 2.17 > 6 (EBITDA TTM 480.4m / Interest Expense TTM 93.9m) |
Altman Z'' 3.36
| A: 0.09 (Total Current Assets 3.28b - Total Current Liabilities 2.24b) / Total Assets 11.42b |
| B: 0.54 (Retained Earnings 6.17b / Total Assets 11.42b) |
| C: 0.02 (EBIT TTM 204.0m / Avg Total Assets 11.33b) |
| D: 0.84 (Book Value of Equity 5.51b / Total Liabilities 6.54b) |
| Altman-Z'' Score: 3.36 = A |
Beneish M -2.94
| DSRI: 1.12 (Receivables 1.12b/999.0m, Revenue 8.82b/8.77b) |
| GMI: 1.04 (GM 57.69% / 60.06%) |
| AQI: 0.96 (AQ_t 0.49 / AQ_t-1 0.51) |
| SGI: 1.01 (Revenue 8.82b / 8.77b) |
| TATA: -0.02 (NI 340.8m - CFO 583.7m) / TA 11.42b) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of PVH shares?
Over the past week, the price has changed by -5.32%, over one month by -1.77%, over three months by -13.22% and over the past year by -10.18%.
Is PVH a buy, sell or hold?
- StrongBuy: 6
- Buy: 3
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PVH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 96 | 47.9% |
| Analysts Target Price | 96 | 47.9% |
PVH Fundamental Data Overview March 04, 2026
P/E Forward = 5.2659
P/S = 0.3634
P/B = 0.6251
P/EG = 0.3375
Revenue TTM = 8.82b USD
EBIT TTM = 204.0m USD
EBITDA TTM = 480.4m USD
Long Term Debt = 2.25b USD (from longTermDebt, last quarter)
Short Term Debt = 352.8m USD (from shortTermDebt, last quarter)
Debt = 4.26b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.10b USD (from netDebt column, last quarter)
Enterprise Value = 7.30b USD (3.20b + Debt 4.26b - CCE 158.2m)
Interest Coverage Ratio = 2.17 (Ebit TTM 204.0m / Interest Expense TTM 93.9m)
EV/FCF = 16.53x (Enterprise Value 7.30b / FCF TTM 441.9m)
FCF Yield = 6.05% (FCF TTM 441.9m / Enterprise Value 7.30b)
FCF Margin = 5.01% (FCF TTM 441.9m / Revenue TTM 8.82b)
Net Margin = 3.87% (Net Income TTM 340.8m / Revenue TTM 8.82b)
Gross Margin = 57.69% ((Revenue TTM 8.82b - Cost of Revenue TTM 3.73b) / Revenue TTM)
Gross Margin QoQ = 56.35% (prev 57.72%)
Tobins Q-Ratio = 0.64 (Enterprise Value 7.30b / Total Assets 11.42b)
Interest Expense / Debt = 0.54% (Interest Expense 23.2m / Debt 4.26b)
Taxrate = 15.19% (107.2m / 705.7m)
NOPAT = 173.0m (EBIT 204.0m * (1 - 15.19%))
Current Ratio = 1.47 (Total Current Assets 3.28b / Total Current Liabilities 2.24b)
Debt / Equity = 0.87 (Debt 4.26b / totalStockholderEquity, last quarter 4.88b)
Debt / EBITDA = 8.53 (Net Debt 4.10b / EBITDA 480.4m)
Debt / FCF = 9.28 (Net Debt 4.10b / FCF TTM 441.9m)
Total Stockholder Equity = 4.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.01% (Net Income 340.8m / Total Assets 11.42b)
RoE = 6.99% (Net Income TTM 340.8m / Total Stockholder Equity 4.88b)
RoCE = 2.86% (EBIT 204.0m / Capital Employed (Equity 4.88b + L.T.Debt 2.25b))
RoIC = 2.44% (NOPAT 173.0m / Invested Capital 7.08b)
WACC = 5.20% (E(3.20b)/V(7.46b) * Re(11.50%) + D(4.26b)/V(7.46b) * Rd(0.54%) * (1-Tc(0.15)))
Discount Rate = 11.50% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -11.24%
[DCF] Terminal Value 80.82% ; FCFF base≈551.3m ; Y1≈361.9m ; Y5≈165.1m
[DCF] Fair Price = 25.37 (EV 5.26b - Net Debt 4.10b = Equity 1.16b / Shares 45.8m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -26.77 | EPS CAGR: -43.77% | SUE: -4.0 | # QB: 0
Revenue Correlation: -21.02 | Revenue CAGR: -1.52% | SUE: N/A | # QB: 0
EPS next Quarter (2026-04-30): EPS=2.42 | Chg7d=+0.000 | Chg30d=-0.016 | Revisions Net=-1 | Analysts=10
EPS next Year (2027-01-31): EPS=11.94 | Chg7d=+0.009 | Chg30d=-0.056 | Revisions Net=+0 | Growth EPS=+9.5% | Growth Revenue=+1.8%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.7% (Discount Rate 11.5% - Earnings Yield 9.8%)
[Growth] Growth Spread = +1.2% (Analyst 2.9% - Implied 1.7%)